The FDA today finalized two guidances to drive the efficient development of a novel technology that scans a person’s DNA to diagnose genetic diseases, which are usually hereditary, and guide medical treatments.
Read more: FDA finalizes guidances to accelerate the development of reliable, beneficial next generation sequencing-based tests